Elsevier’s Reproductive Health Matters Publishes 2012 Supplement Issue “Pregnancy decisions of women living with HIV”
Amsterdam, December 11, 2012 – Elsevier,a world-leading provider of scientific, technical and medical information products and services, announced today publication of Reproductive Health Matters’ 2012 supplement issue “Pregnancy decisions of women living with HIV”.
The supplement issue focuses on finding ways to work across disciplines with the goal of ensuring that women living with HIV are at the centre of decision-making about their sexual and reproductive health and rights. With the advent of antiretroviral therapy and with continued channeling of resources into HIV services, greater numbers of HIV-positive women are living longer, healthier lives. As a result, they are contending with a range of issues affecting their sexual and reproductive health and rights.
Papers published in the issue highlight a need for stronger evidence-based research; drawing from biomedical, economic, political, legal and social sciences alike. It also recognizes the importance of moving beyond the disciplinary silos to bring perspectives together in order to provide more comprehensive information relevant to the lives of these women. Together these papers are intended to inform and help drive policy, program building, research and advocacy efforts to promote and protect the sexual and reproductive health and rights of women living with HIV.
All papers included in the supplement issue are freely available at: http://www.rhmjournal.org/supplements
# # #
Notes to editors
The supplement issue “Pregnancy decisions of women living with HIV” of Reproductive Health Matters, Volume 20, Issue 39, Supplement pp. 1-140 (December 2012) published by Elsevier, is now available on ScienceDirect.
About Reproductive Health Matters (RHM)
Reproductive Health Matters is published twice a year, in May and November in English, with editions in translation in Arabic, Chinese, French, Hindi, Portuguese, Russian and Spanish. RHM covers laws, policies, research and services that meet women’s reproductive health needs. Each issue focuses on a main theme and includes feature papers, topical papers on other subjects and a round-up of information from published literature.
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+44 207 267 6567